T1	CHEM 29 41	paricalcitol
#1	AnnotatorNotes T1	C0249582; paricalcitol; Organic Chemical · Vitamin · Pharmacologic Substance
T2	PROC 60 76	trasplante renal
#2	AnnotatorNotes T2	C0022671; Kidney Transplantation; Therapeutic or Preventive Procedure
T3	CHEM 108 120	paricalcitol
#3	AnnotatorNotes T3	C0249582; paricalcitol; Organic Chemical · Vitamin · Pharmacologic Substance
T4	PROC 720 743;778 790	concentraciones séricas de citocinas
T5	CHEM 125 174	activador selectivo del receptor de la vitamina D
T6	PROC 193 204	tratamiento
#4	AnnotatorNotes T6	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T7	DISO 209 239	hiperparatiroidismo secundario
#5	AnnotatorNotes T7	C0020503; Hyperparathyroidism, Secondary; Disease or Syndrome
T8	PROC 258 274	trasplante renal
#6	AnnotatorNotes T8	C0022671; Kidney Transplantation; Therapeutic or Preventive Procedure
T9	ANAT 344 351	renales
#7	AnnotatorNotes T9	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T10	PROC 355 368	trasplantados
#8	AnnotatorNotes T10	C0040732; Transplantation; Therapeutic or Preventive Procedure
T11	PROC 750 790	niveles de expresión génica de citocinas
#9	AnnotatorNotes T11	C4521390; Gene Expression Level Analysis; Laboratory Procedure (?) + C2699541; Cytokine Measurement; Laboratory Procedure (?)
T12	PROC 436 456	estudio exploratorio
#10	AnnotatorNotes T12	C1515369; Therapeutic Exploratory Study; Research Activity
T13	CHEM 504 516	paricalcitol
#11	AnnotatorNotes T13	C0249582; paricalcitol; Organic Chemical · Vitamin · Pharmacologic Substance
T14	PROC 534 550	trasplante renal
#12	AnnotatorNotes T14	C0022671; Kidney Transplantation; Therapeutic or Preventive Procedure
T15	PROC 586 599	trasplantados
#13	AnnotatorNotes T15	C0040732; Transplantation; Therapeutic or Preventive Procedure
T16	DISO 604 634	hiperparatiroidismo secundario
#14	AnnotatorNotes T16	C0020503; Hyperparathyroidism, Secondary; Disease or Syndrome
T17	PROC 1015 1021	calcio
#15	AnnotatorNotes T17	C0201925; Calcium measurement; Laboratory Procedure
T18	PROC 658 665	terapia
#16	AnnotatorNotes T18	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T19	ANAT 736 743	séricas
#17	AnnotatorNotes T19	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T20	CHEM 781 790	citocinas
#18	AnnotatorNotes T20	C0079189; cytokine; Amino Acid, Peptide, or Protein · Immunologic Factor
T21	PROC 1158 1163	TNF-α
#19	AnnotatorNotes T21	C1168005; Alpha tumour necrosis factor measurement; Laboratory Procedure
T22	ANAT 808 850	células mononucleares de sangre periférica
#20	AnnotatorNotes T22	C1321301; Peripheral blood mononuclear cell; Cell
T23	CHEM 902 914	paricalcitol
#21	AnnotatorNotes T23	C0249582; paricalcitol; Organic Chemical · Vitamin · Pharmacologic Substance
T24	PROC 960 991	niveles de hormona paratiroidea
#22	AnnotatorNotes T24	C0202159; Parathyroid hormone measurement; Laboratory Procedure
T25	PROC 1024 1031	fósforo
#23	AnnotatorNotes T25	C0202178; Phosphorus measurement; Laboratory Procedure
T26	ANAT 1085 1092	séricas
#24	AnnotatorNotes T26	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T27	CHEM 1099 1118	interleucina (IL)-6
#25	AnnotatorNotes T27	C0021760; interleukin-6; Amino Acid, Peptide, or Protein · Immunologic Factor | C1698754; IL6 protein, human; Amino Acid, Peptide, or Protein · Biologically Active Substance | C2983957; interleukin-6, human; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T28	PROC 1125 1156	factor de necrosis tumoral alfa
#26	AnnotatorNotes T28	C1168005; Alpha tumour necrosis factor measurement; Laboratory Procedure
T29	PROC 1287 1325	niveles de expresión génica de la IL-6
#27	AnnotatorNotes T29	C4521390; Gene Expression Level Analysis; Laboratory Procedure (?) + C2699541; Cytokine Measurement; Laboratory Procedure (?)
T30	CHEM 1321 1325	IL-6
#28	AnnotatorNotes T30	C0021760; interleukin-6; Amino Acid, Peptide, or Protein · Immunologic Factor | C1698754; IL6 protein, human; Amino Acid, Peptide, or Protein · Biologically Active Substance | C2983957; interleukin-6, human; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T31	ANAT 1341 1383	células mononucleares de sangre periférica
#29	AnnotatorNotes T31	C1321301; Peripheral blood mononuclear cell; Cell
T32	PROC 1531 1536	TNF-α
#30	AnnotatorNotes T32	C1168005; Alpha tumour necrosis factor measurement; Laboratory Procedure
T33	PROC 1503 1512	citocinas
#31	AnnotatorNotes T33	C2699541; Cytokine Measurement; Laboratory Procedure
T34	PROC 1539 1543	IL-6
#32	AnnotatorNotes T34	C0919829; Interleukin 6 Measurement; Laboratory Procedure
T35	PROC 1567 1572	IL-10
#33	AnnotatorNotes T35	C2697758; Interleukin 10 Measurement; Laboratory Procedure
T36	ANAT 1597 1604	séricos
#34	AnnotatorNotes T36	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T37	CHEM 1716 1728	paricalcitol
#35	AnnotatorNotes T37	C0249582; paricalcitol; Organic Chemical · Vitamin · Pharmacologic Substance
T38	PROC 1745 1761	trasplante renal
#36	AnnotatorNotes T38	C0022671; Kidney Transplantation; Therapeutic or Preventive Procedure
T39	DISO 1806 1825	estado inflamatorio
#37	AnnotatorNotes T39	C0021368; Inflammation; Pathologic Function
T40	PROC 1332 1337	TNF-α
#38	AnnotatorNotes T40	C1168005; Alpha tumour necrosis factor measurement; Laboratory Procedure
T41	ANAT 71 76	renal
#39	AnnotatorNotes T41	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T42	ANAT 269 274	renal
#40	AnnotatorNotes T42	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T43	ANAT 545 550	renal
#41	AnnotatorNotes T43	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T44	CHEM 670 682	paricalcitol
#42	AnnotatorNotes T44	C0249582; paricalcitol; Organic Chemical · Vitamin · Pharmacologic Substance
T45	CHEM 971 991	hormona paratiroidea
#43	AnnotatorNotes T45	C0030520; parathyroid hormone; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T46	PROC 1069 1118	concentraciones séricas de la interleucina (IL)-6
#44	AnnotatorNotes T46	C2208839; serum interleukin-6; Laboratory Procedure
T47	PROC 1697 1711	administración
#45	AnnotatorNotes T47	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T48	ANAT 1756 1761	renal
#46	AnnotatorNotes T48	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T49	LIVB 334 343	pacientes
#47	AnnotatorNotes T49	C0030705; Patients; Patient or Disabled Group
T50	Neg_cue 352 354	no
T51	LIVB 576 585	pacientes
#48	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
T52	Duration 647 654	3 meses
T53	Route 683 687	oral
#49	AnnotatorNotes T53	C1527415; Oral Route of Drug administration; Functional Concept
T54	Dose 689 693	1 μg
T55	Frequency 693 697	/día
T56	PHYS 761 777	expresión génica
#50	AnnotatorNotes T56	C0017262; Gene Expression; Genetic Function
T58	PHYS 1298 1314	expresión génica
#51	AnnotatorNotes T58	C0017262; Gene Expression; Genetic Function
T59	PHYS 1622 1638	expresión génica
#52	AnnotatorNotes T59	C0017262; Gene Expression; Genetic Function
T61	GENE 771 777	génica
#53	AnnotatorNotes T61	C0017337; Genes; Gene or Genome
T64	GENE 1308 1314	génica
#54	AnnotatorNotes T64	C0017337; Genes; Gene or Genome
T66	GENE 1632 1638	génica
#55	AnnotatorNotes T66	C0017337; Genes; Gene or Genome
T67	PHYS 8 24	antiinflamatorio
#56	AnnotatorNotes T67	C1516019; Antiinflammatory Effect; Physiologic Function
T68	PHYS 390 407	antiinflamatorias
#57	AnnotatorNotes T68	C1516019; Antiinflammatory Effect; Physiologic Function
T69	PHYS 483 499	antiinflamatorio
#58	AnnotatorNotes T69	C1516019; Antiinflammatory Effect; Physiologic Function
T70	LIVB 48 56	receptor
#59	AnnotatorNotes T70	C0376387; Transplant Recipients; Patient or Disabled Group
T71	LIVB 520 530	receptores
#60	AnnotatorNotes T71	C0376387; Transplant Recipients; Patient or Disabled Group
T72	LIVB 246 254	receptor
#61	AnnotatorNotes T72	C0376387; Transplant Recipients; Patient or Disabled Group
T73	LIVB 1731 1741	receptores
#62	AnnotatorNotes T73	C0376387; Transplant Recipients; Patient or Disabled Group
A1	Assertion T10 Negated
R1	Negation Arg1:T50 Arg2:T10	
T57	Neg_cue 993 996	sin
T60	CONC 997 1004	cambios
A2	Assertion T60 Negated
#63	AnnotatorNotes T60	C0443172; Changed status; Quantitative Concept
R2	Negation Arg1:T57 Arg2:T60	
R3	Experiences Arg1:T70 Arg2:T1	
R4	Experiences Arg1:T70 Arg2:T2	
R5	Location_of Arg1:T41 Arg2:T2	
R6	Experiences Arg1:T70 Arg2:T67	
R7	Used_for Arg1:T5 Arg2:T6	
R8	Used_for Arg1:T3 Arg2:T6	
R9	Experiences Arg1:T72 Arg2:T3	
R10	Experiences Arg1:T72 Arg2:T5	
R11	Experiences Arg1:T72 Arg2:T8	
R12	Location_of Arg1:T42 Arg2:T8	
R13	Experiences Arg1:T72 Arg2:T7	
R14	Experiences Arg1:T49 Arg2:T10	
R15	Location_of Arg1:T9 Arg2:T10	
R16	Experiences Arg1:T49 Arg2:T68	
R17	Experiences Arg1:T71 Arg2:T69	
R18	Experiences Arg1:T71 Arg2:T13	
R19	Experiences Arg1:T71 Arg2:T14	
R20	Location_of Arg1:T43 Arg2:T14	
R21	Causes Arg1:T1 Arg2:T67	
R22	Causes Arg1:T13 Arg2:T69	
R23	Experiences Arg1:T51 Arg2:T15	
R24	Experiences Arg1:T51 Arg2:T16	
R25	Has_Duration_or_Interval Arg1:T44 Arg2:T52	
R26	Used_for Arg1:T44 Arg2:T18	
R27	Has_Route_or_Mode Arg1:T44 Arg2:T53	
R28	Has_Dose_or_Strength Arg1:T44 Arg2:T54	
R29	Has_Frequency Arg1:T44 Arg2:T55	
R30	Experiences Arg1:T51 Arg2:T18	
R31	Location_of Arg1:T19 Arg2:T4	
#64	AnnotatorNotes T4	C4700779; serum or plasma cytokines; Laboratory Procedure
T62	Quantifier_or_Qualifier 791 804	inflamatorias
R32	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T62	
T63	CONC 854 860;872 883	inicio del estudio
#65	AnnotatorNotes T63	C4684789; Study Start; Temporal Concept
T65	CONC 866 883	final del estudio
#66	AnnotatorNotes T65	C2983670; Study End Date; Temporal Concept
R33	Overlap Arg1:T4 Arg2:T65	
R34	Overlap Arg1:T4 Arg2:T63	
R35	Overlap Arg1:T11 Arg2:T63	
R36	Overlap Arg1:T11 Arg2:T65	
T74	Observation 927 938;953 991	disminución en los niveles de hormona paratiroidea
#67	AnnotatorNotes T74	C0856879; Parathyroid hormone decreased; Finding
R37	Causes Arg1:T23 Arg2:T74	
R38	Before Arg1:T23 Arg2:T60	
R39	Location_of Arg1:T26 Arg2:T46	
T75	Observation 1052 1118	reducción en las concentraciones séricas de la interleucina (IL)-6
#68	AnnotatorNotes T75	C0919836; Interleukin-6 decreased; Finding
T76	Observation 1052 1061;1121 1164	reducción del factor de necrosis tumoral alfa (TNF-α)
#69	AnnotatorNotes T76	C1168007; Alpha tumour necrosis factor decreased; Finding
T77	CONC 1207 1219	estado basal
#70	AnnotatorNotes T77	C1442488; Baseline; Quantitative Concept
R40	Before Arg1:T77 Arg2:T76	
R41	Before Arg1:T77 Arg2:T75	
T78	Observation 1287 1325;1402 1410	niveles de expresión génica de la IL-6 descenso
#71	AnnotatorNotes T78	C0919836; Interleukin-6 decreased; Finding
T79	Observation 1287 1294;1328 1337;1402 1410	niveles del TNF-α descenso
#72	AnnotatorNotes T79	C1168007; Alpha tumour necrosis factor decreased; Finding
T80	Quantifier_or_Qualifier 1513 1529	proinflamatorias
R42	Has_Quantifier_or_Qualifier Arg1:T33 Arg2:T80	
T81	Quantifier_or_Qualifier 1550 1566	antiinflamatoria
R43	Has_Quantifier_or_Qualifier Arg1:T33 Arg2:T81	
R44	Location_of Arg1:T36 Arg2:T35	
R45	Location_of Arg1:T36 Arg2:T34	
R46	Location_of Arg1:T36 Arg2:T32	
R47	Location_of Arg1:T36 Arg2:T33	
R48	Used_for Arg1:T37 Arg2:T47	
R49	Experiences Arg1:T73 Arg2:T47	
R50	Experiences Arg1:T73 Arg2:T38	
R51	Location_of Arg1:T48 Arg2:T38	
T82	Observation 1776 1796	efectos beneficiosos
#73	AnnotatorNotes T82	C4049461; Unexpected beneficial therapeutic response; Finding (?)
R52	Causes Arg1:T47 Arg2:T82	
R54	Experiences Arg1:T73 Arg2:T82	
R55	Experiences Arg1:T73 Arg2:T39	
T83	Spec_cue 1856 1865	potencial
T84	Observation 1866 1883	beneficio clínico
A3	Assertion T84 Speculated
R56	Speculation Arg1:T83 Arg2:T84	
R57	Before Arg1:T47 Arg2:T84	
T85	Observation 1531 1536;1648 1657	TNF-α disminuyó
#74	AnnotatorNotes T85	C1168007; Alpha tumour necrosis factor decreased; Finding
T86	Observation 1539 1543;1648 1657	IL-6 disminuyó
#75	AnnotatorNotes T86	C0919836; Interleukin-6 decreased; Finding
T87	Observation 1567 1572;1648 1657	IL-10 disminuyó
R58	Location_of Arg1:T22 Arg2:T11	
R59	Location_of Arg1:T22 Arg2:T4	
R60	Has_Quantifier_or_Qualifier Arg1:T49 Arg2:T9	
R61	Location_of Arg1:T31 Arg2:T40	
R62	Location_of Arg1:T31 Arg2:T29	
R63	Location_of Arg1:T26 Arg2:T28	
R64	Overlap Arg1:T60 Arg2:T17	
R65	Overlap Arg1:T60 Arg2:T25	
R66	Location_of Arg1:T26 Arg2:T75	
R67	Location_of Arg1:T26 Arg2:T76	
R68	Location_of Arg1:T31 Arg2:T79	
R69	Location_of Arg1:T31 Arg2:T78	
R70	Location_of Arg1:T36 Arg2:T85	
R71	Location_of Arg1:T36 Arg2:T87	
R72	Location_of Arg1:T36 Arg2:T86	
#76	AnnotatorNotes T84	C4049461; Unexpected beneficial therapeutic response; Finding (?)
#77	AnnotatorNotes T81	C4751299; Antiinflammatory therapeutic role; Intellectual Product
#78	AnnotatorNotes T87	C5676758; Reduced circulating interleukin 10 concentration; Finding (?)
#79	AnnotatorNotes T62	C0333348; Inflammatory; Functional Concept
A4	Experiencer T70 Patient
A5	Experiencer T72 Patient
A6	Experiencer T49 Patient
A7	Experiencer T71 Patient
A8	Experiencer T51 Patient
A9	Experiencer T73 Patient
R53	Has_Result_or_Value Arg1:T40 Arg2:T79	
R73	Has_Result_or_Value Arg1:T29 Arg2:T78	
R74	Has_Result_or_Value Arg1:T24 Arg2:T74	
R75	Has_Result_or_Value Arg1:T28 Arg2:T76	
R76	Has_Result_or_Value Arg1:T21 Arg2:T76	
R77	Has_Result_or_Value Arg1:T32 Arg2:T85	
R78	Has_Result_or_Value Arg1:T34 Arg2:T86	
R79	Has_Result_or_Value Arg1:T35 Arg2:T87	
